Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Yung, Lyou"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/877b7439e6fb403fbe50735d7b242457
Publikováno v:
Frontiers in Oncology; 2024, p1-4, 4p
Autor:
Daniela V. Castro, Zeynep B. Zengin, Jasnoor Malhotra, Cristiane D. Bergerot, Luis Meza, Nazli Dizman, Ameish Govindarajan, JoAnn Hsu, Alex Chehrazi-Raffle, Neal Chawla, Benjamin D. Mercier, Sean W. Chen, Matthew Feng, Sweta Prajapati, Kyle O. Lee, Errol J. Philip, Tanya B. Dorff, Yung Lyou, Sumanta K. Pal
Publikováno v:
Cancer Investigation. 41:70-76
Since the approval of the COVID-19 vaccines, their safety and efficacy has been widely demonstrated in patients with cancer. However, there remain patients with reservations regarding vaccination. We aimed to assess genitourinary cancer patients' per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d833bb78b9cc223a3d83277f66c19ce5
https://doi.org/10.1080/07357907.2022.2136683
https://doi.org/10.1080/07357907.2022.2136683
Autor:
Paulo Gustavo Bergerot, Nazli Dizman, Yung Lyou, Nicholas Salgia, Daniel Enriquez, Tyler Izatt, Jeffrey M Trent, Sara Byron
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background The clinical significance of tumor-specific genomic alterations in metastatic renal cell carcinoma (mRCC) is emerging, with several studies suggesting an association between PBRM1 mutations and response with immunotherapy (IO). We sought t
Externí odkaz:
https://doaj.org/article/3513da1694804e69aab6fb446c27e65d
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 2, Pp 360-364 (2018)
Breast cancer is the second leading cause of cancer-related deaths in women in the United States. Of these women, 5–10% have an inherited form of breast cancer with a mutation in a major gene, such as the breast cancer susceptibility genes 1 or 2 (
Externí odkaz:
https://doaj.org/article/ee174b63aa4948e4a5a30f26b88eb537
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 1, Pp 216-220 (2018)
In the last couple of decades, breast conservation therapy, which utilizes a combination of surgery, radiotherapy, and endocrine or chemotherapy, has become the standard of care for treating early-stage breast cancer. This practice has been greatly b
Externí odkaz:
https://doaj.org/article/7e6eeb4565a646f5ac6d04dcddbba3ce
Autor:
Claire, Hao, Colton, Ladbury, Yung, Lyou, Saro, Manoukian, Christopher, Ruel, Paul, Frankel, Tanya, Dorff, Jeffrey, Wong, Sumanta, Pal, Przemyslaw, Twardowski, Savita, Dandapani
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:705-710
External beam radiation therapy (EBRT) to oligometastases may improve outcomes in patients with oligometastatic hormone-sensitive prostate cancer (oHSPC). Follow-up on this cohort has been limited to5 years and prospective data on de novo patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b18f18e58824c10f8274c136fa52ffe
https://doi.org/10.1016/j.ijrobp.2022.06.085
https://doi.org/10.1016/j.ijrobp.2022.06.085
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 3, Pp 854-860 (2016)
Composite lymphoma (CL) is a rare disease with 2 distinct lymphomas concurrently arising in a single patient with an estimated incidence of 1–4.7% of newly diagnosed lymphomas per year. CL most commonly involves 2 B-cell non-Hodgkin lymphomas (NHL)
Externí odkaz:
https://doaj.org/article/f539b7362e9647fe95de296e797cd3ec
Autor:
Marian L. Waterman, Robert A. Edwards, Ali Mortazavi, Linzi Hosohama, Madeleine R. Duong, Yung Lyou, Amber N. Habowski, Rabi Murad, Delia F. Tifrea, George T. Chen
Supplementary Data from Disruption of β-Catenin–Dependent Wnt Signaling in Colon Cancer Cells Remodels the Microenvironment to Promote Tumor Invasion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8962c75ce3513d55fa3c9c0b6ea2a389
https://doi.org/10.1158/1541-7786.22528254.v1
https://doi.org/10.1158/1541-7786.22528254.v1
Autor:
Marian L. Waterman, Robert A. Edwards, Ali Mortazavi, Linzi Hosohama, Madeleine R. Duong, Yung Lyou, Amber N. Habowski, Rabi Murad, Delia F. Tifrea, George T. Chen
The recent classification of colon cancer into molecular subtypes revealed that patients with the poorest prognosis harbor tumors with the lowest levels of Wnt signaling. This is contrary to the general understanding that overactive Wnt signaling pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a5583c819e23efb822c87e3e6dbc736
https://doi.org/10.1158/1541-7786.c.6545667.v1
https://doi.org/10.1158/1541-7786.c.6545667.v1